Five things for pharma marketers to know: Monday, August 6, 2018

Regeneron invests $100 million in bluebird; Boehringer Ingelheim starts cystic fibrosis coalition; FDA rejects Pain Therapeutics' application to sell Remoxy.

from Most popular articles from Medical Marketing and Media https://ift.tt/2Mo6Igr